Savient Pharmaceuticals, Inc. to Present At JMP Securities 4th Annual Healthcare Focus Conference

EAST BRUNSWICK, N.J., Oct. 1, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Paul Hamelin, President of Savient Pharmaceuticals, will be presenting at the upcoming JMP Securities 4th Annual Healthcare Focus Conference on October 6, 2009.

MORE ON THIS TOPIC